Opens in a new tab

Dr. Zeng Guohua

Chinese name: 曾国华
Chief Physician, Professor, Doctoral Supervisor . Urology & Minimally Invasive Surgery
Dr. Zeng Guohua is Vice President of the First Affiliated Hospital of Guangzhou Medical University and Director of its Minimally Invasive Surgery Centre. A leading authority on urolithiasis in China, he invented the super-mini percutaneous nephrolithotomy (SMP) technique and promotes minimally invasive stone management worldwide through the International Alliance of Urolithiasis.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

30+ years
Minimally invasive stone management
20,000+ cases
Minimally invasive stone surgeries performed
200+ papers
First/corresponding-author SCI publications

  • The Physician

About Dr. Zeng Guohua

Dr. Zeng Guohua is Vice President of the First Affiliated Hospital of Guangzhou Medical University, Director of its Minimally Invasive Surgery Centre and Director of the Guangdong Key Laboratory of Urology. He has devoted more than three decades to urolithiasis and minimally invasive urology, and invented the super-mini percutaneous nephrolithotomy (SMP) technique, which is now used worldwide. He leads the International Alliance of Urolithiasis and has led multicentre randomised trials comparing mini and standard percutaneous nephrolithotomy. He received the Wu Jieping Urology Award in 2016.
1、Vice President of the First Affiliated Hospital of Guangzhou Medical University and Director of the Minimally Invasive Surgery Centre
2、Director of the Guangdong Key Laboratory of Urology and the Guangzhou Institute of Urology
3、Academic leader of the national key clinical specialty in urology
4、Inventor and international promoter of the super-mini percutaneous nephrolithotomy (SMP) technique
5、Chairman of the Urology Branch of the Guangdong Medical Doctor Association
6、Recipient of the Wu Jieping Urology Award (2016)
7、Leader of the International Alliance of Urolithiasis (IAU) consensus on miniaturised percutaneous nephrolithotomy

Dr. Zeng Guohua ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Kidney stones (urolithiasis)

He treats kidney and ureteral stones with minimally invasive techniques including mini and super-mini percutaneous nephrolithotomy, flexible ureteroscopy and shock-wave lithotripsy, selecting the least invasive approach to achieve complete stone clearance and protect kidney function in complex and high-risk cases.

Prostate disease

He diagnoses and treats benign prostatic hyperplasia and prostate cancer with minimally invasive and robot-assisted surgery, and provides individualised medical and surgical management based on tumour risk and urinary symptoms, helping older men preserve urinary and sexual function and quality of life.

Urinary tract tumours and strictures

He performs minimally invasive surgery for bladder, kidney and upper urinary tract tumours, and manages urethral and ureteral strictures with endoscopic and reconstructive techniques, aiming to remove disease completely while preserving renal function and normal voiding and improving patients' long-term outcomes.

More： ureteral stones——ureteroscopy; kidney tumours——partial nephrectomy; adrenal disease——laparoscopic surgery; urinary infection——management; paediatric urology——minimally invasive surgery

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Mini-percutaneous nephrolithotomy versus standard PCNL for 20-40 mm renal stones
A multicenter, randomized, noninferiority trial comparing mini-percutaneous nephrolithotomy with standard percutaneous nephrolithotomy for treating twenty to forty millimeter kidney stones, showing comparable stone-free rates with less bleeding and shorter hospital stays for patients with large and complex renal stones in this trial.
2. Suction mini-PCNL versus standard PCNL for 2-4 cm renal stones
A registered multicenter randomized trial comparing suction-assisted mini-percutaneous nephrolithotomy with standard percutaneous nephrolithotomy for the treatment of two to four centimeter kidney stones, evaluating stone-free rate, bleeding and recovery in patients with complex renal stone disease requiring minimally invasive surgical intervention.
3. Enhanced super-mini-percutaneous nephrolithotomy (eSMP) randomized trial
A randomized controlled trial evaluating the enhanced super-mini-percutaneous nephrolithotomy system for treating kidney stones, demonstrating improved endoscopic vision, better stone clearance and reduced operative complications compared with earlier minimally invasive PCNL systems for patients with renal stones and complex anatomy.
4. EAU-IAU joint consensus on percutaneous nephrolithotomy
A joint consensus document from the European Association of Urology and the International Alliance of Urolithiasis standardizing patient selection, tract size, surgical technique and follow-up for percutaneous nephrolithotomy, improving the safety and outcomes of kidney stone surgery worldwide for patients.
5. International Alliance of Urolithiasis guideline on percutaneous nephrolithotomy
An international guideline developed by the International Alliance of Urolithiasis describing best practice for percutaneous nephrolithotomy, covering preoperative imaging, access techniques, stone fragmentation and complication management for patients with complex kidney and upper urinary tract stones worldwide in adults and children.
6. Miniaturised percutaneous nephrolithotomy: role in urolithiasis and our experience
A review summarizing the classification, instruments and clinical role of miniaturized percutaneous nephrolithotomy techniques, including super-mini-PCNL, and the authors long experience in treating kidney and upper urinary tract stones with minimally invasive surgery in adults and children over several decades.
  • Affiliated Hospital

Where Dr. Zeng Guohua practices

Guangzhou

The First Affiliated Hospital of Guangzhou Medical University

Chinese name: 广州医科大学附属第一医院
Guangzhou Medical University First Affiliated Hospital, founded in 1903 and led by respiratory scientist Academician Zhong Nanshan, hosts the National Respiratory Medical Center and a national key laboratory, offering 13 national key specialties across 2,850 beds as one of China's leading respiratory-care institutions.
Since 1903
123 years of care
2,850
Licensed beds
15
National-level platforms
Host institution
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Zeng Guohua?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Zeng Guohua.